updated Mon. May 30, 2022
March 2, 2018
Denner came to prominence working with Icahn on a number of biotech investments that resulted in sales, including ImClone Systems to Eli Lilly in 2008 for $6.5 billion, and Genzyme to Sanofi in 2011 for $20.1 billion. Denner split with Icahn in 2012 to form Sarissa. In January 2017, he orchestrated theÃÂ ...
February 23, 2018
Law360 (February 23, 2018, 9:11 PM EST) -- So far in February, Alston & Bird LLP lost an FDA-focused attorney to Goodwin Procter LLP and gained a government contracts attorney from Dentons, and intellectual property boutique Lucas & Mercanti LLP announced the arrival of three attorneys specializing in pharma.
February 16, 2018
According to new report available with Million Insights, On a commercial scale, protein kinase inhibitors help in diagnosing cancer patients and also the rise in demand for custom treatments has been a prime feature in the growth of protein kinase inhibitor market. Overall, with the product innovation and novel therapies theÃÂ ...
February 11, 2018
... Adare Pharmaceuticals Incorporated, Allergan plc, Amgen Incorporated, Baxter International Incorporated, Becton, Dickinson, and Company, Boehringer Ingelheim GmbH, Braun (B.) Melsungen AG, Hospira, see Pfizer, ImClone Systems, see Lilly (Eli), Janssen Pharmaceuticals, see Johnson & Johnson,ÃÂ ...
February 5, 2018
... Lilly& Company's Global Oncology Unit following the company's 2008 acquisition of ImClone Systems Incorporated, where he served as chief executive officer and on ImClone's board. Prior to ImClone, Mr.Johnson served as the company group chairman of biopharmaceuticals within Johnson& Johnson,ÃÂ ...
April 7, 2011
[Updated: 10:20 pm, 4/15/11] ImClone Systems is the biotech company that Martha Stewart made famous, but after the scandalous headlines faded away, it has left a lasting imprint on New York. The ImClone story has been told many times over, about the 2001 insider trading allegation that ended upÃÂ ...
New York Times
October 8, 2008
Eli Lilly agreed on Monday to pay $6.5 billion to acquire ImClone Systems, the biotechnology company that is controlled by Carl C. Icahn and whose stock was involved in the insider trading scandal that sent Martha Stewart to jail. The deal by Lilly, worth $70 a share, beat out an offer of $62 a share fromÃÂ ...
The Legman News
December 31, 1999
... AbbVie Incorporated , Actavis, see Allergan , Adare Pharmaceuticals Incorporated , Allergan plc , Amgen Incorporated , Baxter International Incorporated , Becton, Dickinson, and Company , Boehringer Ingelheim GmbH , Braun (B.) Melsungen AG , Hospira, see Pfizer , ImClone Systems, see Lilly (Eli)ÃÂ ...
news and opinion